https://www.selleckchem.com/pr....oducts/leukadherin-1
INTRODUCTION Currently fetal nuchal translucency (NT) ≥3.5mm is an indication for invasive testing often followed by chromosomal microarray. The aim of this study was to assess the risks for chromosomal aberrations in fetuses with a NT 3.0-3.4 mm, to determine whether invasive prenatal testing would be relevant in these cases and to assess the residual risks in fetuses with normal non-invasive prenatal test (NIPT) results. MATERIAL AND METHODS A retrospective study and meta-analysis of literature cases with NT between 3.0-3.4 mm a
Like
Comment
Share
